|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Anxiety disorders were more common in full siblings and half-siblings of people with ASD.The implications of this are explored.
|
31621020 |
2020 |
|
Anxiety Disorders
|
0.100 |
AlteredExpression
|
group |
BEFREE |
As to anxiety, it is not the main characteristics of ASD, but represents one of the most common its co morbidities.
|
31437571 |
2019 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
This study examines inadequately explored tolerability and effectiveness of buspirone in treating ADs comorbid with high-functioning ASD.
|
30452283 |
2019 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Our findings emphasise the need to provide timely assessment and treatment of anxiety and depression in ASD.
|
31190198 |
2019 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Group differences in brain activation disappeared when either alexithymia or anxiety - both elevated in the ASD group - were controlled for.
|
29683406 |
2019 |
|
Anxiety Disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
As expected, many of these include animal model equivalents of the "core" phenotypes associated with ASD, such as impairments in social behavior and repetitive behavior, as well as several comorbid features of ASD including anxiety, seizures, and motor-control deficits.
|
30911366 |
2019 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Maternal anxiety or depression was associated with 2.7 times the odds (95% confidence interval: 1.4, 5.3) of Type 4 or Dysregulated ASD in the child; maternal anxiety and depression was associated with 4.4 times the odds (95% confidence interval: 1.4, 14.0) of Type 4 or Dysregulated ASD in the child.
|
30128718 |
2019 |
|
Anxiety Disorders
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Symptoms of ASD were found to influence elevated levels of parent-rated GAD indirectly through greater levels of sensory avoiding, and auditory-specific sensory behaviours correlated with parent-rated anxiety more strongly than other sensory modalities.
|
30771129 |
2019 |
|
Anxiety Disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
There was no significant difference in risks for ADHD (OR = 1.563; 95% CI, 1.382-1.769); sleep disorders (OR = 2.100; 95% CI, 1.322-3.336); anxiety (OR = 1.339; 95% CI, 1.062-1.687); depression (OR = 1.402 95% CI, 1.256-1.565); conduct disorder (OR = 1.494 95% CI, 1.230-1.815); or ASD (OR = 2.574; 95% CI, 1.469-4.510; <i>Q</i><sub>b</sub> = 8.344, <i>p</i> = 0.138).
|
31447731 |
2019 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings bear strong resemblance to the pattern seen in ASD and emphasize the need for development of anxiety interventions that attempt to reduce negative beliefs about unpredictable situations in WS.
|
29948532 |
2018 |
|
Anxiety Disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We conducted a meta-synthesis to explore what strategies parents use to manage irritability, non-compliance, challenging behaviour and anxiety in their children with ASD.
|
29222612 |
2018 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Encouragingly, our findings suggest that HADS provides a reliable and valid assessment of anxiety and depression in ASD.
|
28922575 |
2018 |
|
Anxiety Disorders
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Youth with ASD without co-occurring intellectual disability experience high levels of intolerance of uncertainty (IU), which is related to anxiety.
|
29316350 |
2018 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Brief Report: Bullying and Anxiety in High-Functioning Adolescents with ASD.
|
29152669 |
2018 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Key themes include recognition of the importance individual differences in aetiology and presentation of anxiety in ASD, the need for a more nuanced understanding of the interactions between anxiety and characteristics of ASD and the need to develop appropriately adapted treatments.
|
28988366 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Results suggest that youth with ASD and co-occurring anxiety have a distinct neurodevelopmental trajectory.
|
28689329 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Additionally, deep phenotyping revealed overlapping behavioral problems (ASD, ADHD, and anxiety disorders), hypotonia, broad-based gait, facial dysmorphisms, and periods of fever and vomiting.
|
28343630 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
The study's limitations, the use of the SCAS-P to screen for DSM-derived anxiety problems in ASD and future research directions are discussed.Autism Res 2017, 10: 1629-1652.
|
28574646 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Findings stress the importance of parent (father) and family factors in the treatment of anxiety disorders in youth with ASD.
|
28004234 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Findings demonstrated that young people with ASD can self-report and show insight in to their RRB, and replicated previous findings based on parent report showing a significant positive relationship between RRB and anxiety.
|
28238024 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
This follow-up study investigated changes in caregiver-reported anxiety in 54 non-referred youth with ASD after 10-19 months.
|
28451947 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
This study evaluated change in social skills during a randomized controlled trial of CBT and during the 1-year follow-up for 25 adolescents with ASD and anxiety.
|
27040557 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
In this cross-sectional study, we assessed social media use, anxiety and friendship quality in 44 adolescents with ASD, and 56 clinical comparison controls.
|
28616856 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Thirty-five young people (11-14 years; IQ > 70) with ASD and elevated teacher or parent reported anxiety were randomly assigned to 6 sessions of the Exploring Feelings CBT intervention (Attwood in Exploring feelings (anxiety).
|
27440250 |
2017 |
|
Anxiety Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
The aim of the present study was to examine the association between a variable number tandem repeat (VNTR) functional polymorphism in the promoter region of the MAO-A gene and severity of ADHD and anxiety in boys with ASD.
|
18566880 |
2009 |